Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$152,075
-6.81%
Shares
Shares Volume: 5,500 Shares
Average Share Price: $27.65
INSIDER
Yale Catriona
Chief Development Officer (Officer)
reported on Sep 23 2024
traded on Sep 19 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 75,294 |
| PURCHASES/SALES 1Y | 0 / 9 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $211,117.21 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 2 / 41 |
| P/S VALUE RATIO | 0.226 |
| AVERAGE SALE VALUE | $396,872.83 |
| COMPANY PREVIOUS TRADES |